SREBP1 INDUCES RESISTANCE TO HIF-2α ANTAGONIST IN CLEAR CELL RENAL CELL CARCINOMA

被引：0
|
作者：
Son, Da Hyeon
Lee, Young Ju
Kim, Hyo Eun
Kim, Eun Song
Park, Sung Yul
Yoon, Young Eun
机构：
来源：
JOURNAL OF UROLOGY | 2024年 / 211卷 / 05期
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD51-08
引用
收藏
页码：E1067 / E1068
页数：2
相关论文
共 50 条
  • [1] Therapeutic target for HIF-2α antagonist-resistant clear cell renal cell carcinoma
    Son, D. H.
    Hong, S. H.
    Hwang, H. J.
    Kim, E. S.
    Park, S. Y.
    Yoon, Y. E.
    EUROPEAN UROLOGY, 2023, 83
  • [2] Targeting renal cell carcinoma with a HIF-2 antagonist
    Chen, Wenfang
    Hill, Haley
    Christie, Alana
    Kim, Min Soo
    Holloman, Eboni
    Pavia-Jimenez, Andrea
    Homayoun, Farrah
    Ma, Yuanqing
    Patel, Nirav
    Yell, Paul
    Hao, Guiyang
    Yousuf, Qurratulain
    Joyce, Allison
    Pedrosa, Ivan
    Geiger, Heather
    Zhang, He
    Chang, Jenny
    Gardner, Kevin H.
    Bruick, Richard K.
    Reeves, Catherine
    Hwang, Tae Hyun
    Courtney, Kevin
    Frenkel, Eugene
    Sun, Xiankai
    Zojwalla, Naseem
    Wong, Tai
    Rizzi, James P.
    Wallace, Eli M.
    Josey, John A.
    Xie, Yang
    Xie, Xian-Jin
    Kapur, Payal
    McKay, Renee M.
    Brugarolas, James
    NATURE, 2016, 539 (7627) : 112 - +
  • [3] Targeting renal cell carcinoma with a HIF-2 antagonist
    Wenfang Chen
    Haley Hill
    Alana Christie
    Min Soo Kim
    Eboni Holloman
    Andrea Pavia-Jimenez
    Farrah Homayoun
    Yuanqing Ma
    Nirav Patel
    Paul Yell
    Guiyang Hao
    Qurratulain Yousuf
    Allison Joyce
    Ivan Pedrosa
    Heather Geiger
    He Zhang
    Jenny Chang
    Kevin H. Gardner
    Richard K. Bruick
    Catherine Reeves
    Tae Hyun Hwang
    Kevin Courtney
    Eugene Frenkel
    Xiankai Sun
    Naseem Zojwalla
    Tai Wong
    James P. Rizzi
    Eli M. Wallace
    John A. Josey
    Yang Xie
    Xian-Jin Xie
    Payal Kapur
    Renée M. McKay
    James Brugarolas
    Nature, 2016, 539 : 112 - 117
  • [4] Re: Targeting Renal Cell Carcinoma with a HIF-2 Antagonist
    Shenoy, Niraj
    Pagliaro, Lance
    EUROPEAN UROLOGY, 2018, 73 (02) : 304 - 305
  • [5] Re: Targeting Renal Cell Carcinoma with a HIF-2 Antagonist
    Ferguson, James E., III
    Matin, Surena F.
    EUROPEAN UROLOGY, 2017, 71 (06) : 987 - 987
  • [6] Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma
    Maeva Dufies
    Annelies Verbiest
    Lindsay S. Cooley
    Papa Diogop Ndiaye
    Xingkang He
    Nicolas Nottet
    Wilfried Souleyreau
    Anais Hagege
    Stephanie Torrino
    Julien Parola
    Sandy Giuliano
    Delphine Borchiellini
    Renaud Schiappa
    Baharia Mograbi
    Jessica Zucman-Rossi
    Karim Bensalah
    Alain Ravaud
    Patrick Auberger
    Andréas Bikfalvi
    Emmanuel Chamorey
    Nathalie Rioux-Leclercq
    Nathalie M. Mazure
    Benoit Beuselinck
    Yihai Cao
    Jean Christophe Bernhard
    Damien Ambrosetti
    Gilles Pagès
    Communications Biology, 4
  • [7] Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma
    Dufies, Maeva
    Verbiest, Annelies
    Cooley, Lindsay S.
    Ndiaye, Papa Diogop
    He, Xingkang
    Nottet, Nicolas
    Souleyreau, Wilfried
    Hagege, Anais
    Torrino, Stephanie
    Parola, Julien
    Giuliano, Sandy
    Borchiellini, Delphine
    Schiappa, Renaud
    Mograbi, Baharia
    Zucman-Rossi, Jessica
    Bensalah, Karim
    Ravaud, Alain
    Auberger, Patrick
    Bikfalvi, Andreas
    Chamorey, Emmanuel
    Rioux-Leclercq, Nathalie
    Mazure, Nathalie M.
    Beuselinck, Benoit
    Cao, Yihai
    Bernhard, Jean Christophe
    Ambrosetti, Damien
    Pages, Gilles
    COMMUNICATIONS BIOLOGY, 2021, 4 (01)
  • [8] Targeting HIF-2 α in clear cell renal cell carcinoma: A promising therapeutic strategy
    Martinez-Saez, Olga
    Borau, Pablo Gajate
    Alonso-Gordoa, Teresa
    Molina-Cerrillo, Javier
    Grande, Enrique
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 111 : 117 - 123
  • [9] Allosteric inhibition of HIF-2 as a novel therapy for clear cell renal cell carcinoma
    Yu, Yancheng
    Yu, Quanwei
    Zhang, Xiaojin
    DRUG DISCOVERY TODAY, 2019, 24 (12) : 2332 - 2340
  • [10] Everolimus resistance in clear cell renal cell carcinoma: miRNA-101 and HIF-2α as molecular triggers?
    Nogueira, Ines
    Dias, Francisca
    Morais, Mariana
    Teixeira, Ana Luisa
    Medeiros, Rui
    FUTURE ONCOLOGY, 2019, 15 (20) : 2361 - 2370
12345